Objective To describe recent changes in policy on provider-initiated testing and counselling (PITC) for human immunodeficiency virus (HIV) infection in African countries and to investigate patients' experiences of and views about PITC.
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From caution to urgency: the evolution of HIV testing and counselling in Africa R Since the first antibody tests for human immunodeficiency virus (HIV) infection became available, public health organizations and human rights activists have debated the best approach to HIV testing and counselling (HTC). 1 At a time when there was no effective treatment and HIV-infected individuals faced widespread discrimination and stigmatization, 1 many argued that HTC was inappropriate because it provided little benefit to the individual. 1, 2 Conversely, others believed that testing was the key to promoting a change in behaviour. 1, 3 These two concerns framed early debates about HTC. 4 Initially, there was general support for a cautious response to HTC and HIV infection, although this was considered "exceptional" compared with responses to other infectious diseases. 1, 5 For example, in 1987, the World Health Organization (WHO) emphasized caution in extending routine HIV testing beyond blood donors. 1 At that time, standards for HTC, which were based on an international consensus reached by WHO and other stakeholders, emphasized voluntarism and gave rise to the adoption of voluntary counselling and testing. 1 This approach consisted of three primary components: counselling before and after an HIV test, which included an individualized risk-reduction plan based on the test results; informed written consent; and confidentiality. 1 As evidence emerged that antiretroviral therapy (ART) could significantly reduce mother-to-child HIV transmission and "alter the clinical course" of HIV infection, the HTC debate changed. 1, 3, 6 Clinicians and public health professionals now argued that an exceptional approach to HTC was no longer appropriate. The view was that HTC should be standard clinical practice in settings where patients present with symptoms of an HIV infection and where ART is available. 1, 2 At first, however, ART was not universally available. The primary aim of this study was to review how policy in African countries has changed in response to the growing recognition that health-care providers should offer more HTC. The rationale for focusing on HTC policy in Africa was, first, that 68% of the estimated 34 million people with HIV infections worldwide at the end of 2010 resided in subSaharan Africa, a region with only 12% of the global population, 21 and, second, that it was important to examine policy responses in settings where there was an urgent need to address low HTC coverage, for example, to prevent mother-to-child HIV transmission or to identify individuals with HIV infections who could benefit from ART.
Methods
National policy documents, strategies, plans, frameworks, guidelines and reports on HIV In addition, the review also considered documents that did not focus on HIV prevention alone but covered relevant broad issues, such as maternal and child health, human rights, tuberculosis and opportunistic infections.
Identified documents were grouped into three categories according to their overall objectives:
• guidelines, manuals, protocols, legislation and policy;
• national strategic plans, strategic frameworks and multisectoral frameworks;
• other literature, including published and unpublished reviews. The date assumed for the adoption of a policy depended largely on the type of documents identified and the strength of the evidence available, with further confirmation being obtained from WHO country representatives. Since the date of publication of legislation, policy, guidelines, manuals and protocols (i.e. the first document category) explicitly indicated the date on which a policy was adopted, this date was used in preference to the dates of other documents. When these documents were not available, the publication date of a strategic plan (i.e. the second document category) was used. However, when the only documents identified belonged to the third category, the date on which a policy was adopted was determined by consultation with WHO country representatives. 
Results
The policies, guidelines or strategic plans on PITC from 52 African countries were reviewed.
Documents for one country could not be retrieved and Western Sahara was not included in the review. There was evidence that a policy had been adopted by 42 (79.2%) of 53 countries (Table 1) , whereas 10 (18.9%) had not adopted a policy: Algeria, Angola, Chad, Egypt, the Libyan Arab Jamahirya, Morocco, the Niger, Sao Tome and Principe and Tunisia ( (Table 1) .
Clinical settings and target populations
All 42 countries that adopted a PITC policy recommended that pregnant women should be covered either in antenatal clinics or in services provided for the prevention of mother-tochild HIV transmission. In addition, 73.8% of the 42 countries adopted a policy of universal PITC, which was defined as offering HTC to all patients or adults visiting a health-care facility. Documents for 66.7% of countries recommended PITC for either tuberculosis patients or clinics, 45.2% recommended it for patients with sexually transmitted infections, 14.3% for family planning clinics, 7.1% for most-at-risk populations and 7.1% for individuals attending out-patient departments.
Patient's perspectives and experience
The literature search identified over 2000 publications, of which 11 were considered eligible for inclusion in the review (Table 2 and Table 3 ). The majority were observational studies: 8 investigated the acceptability of PITC to women or their experiences of it in antenatal clinics, whereas the remaining 3 involved tuberculosis patients, women attending immunization clinics with their infants and patients attending a medical emergency unit.
Overall, the large majority of individuals who received PITC found it acceptable (Table 2 ). For example, in Uganda 98.5% of women who were attending an antenatal clinic for the first time considered the routine offer of HTC during pregnancy "good" or "very good." 26 In South Africa, 93% of women offered HTC while attending midwife obstetric units agreed that all pregnant women should be tested for HIV. 22 Among pregnant women who opted for HTC in a study from Zimbabwe, 89% stated that the routine offer of HTC was helpful and empowering and enabled women to make an informed decision about the prevention of mother-to-child HIV transmission and infant feeding. 24 In addition, experience of PITC was generally regarded as good (Table 3) . For example, in Zimbabwe, 98% of pregnant women stated they were satisfied with the information they received on routine HTC. 24 In South Africa, 52% of pregnant women who had been tested for HIV felt they had made an informed choice and had a positive experience, whereas 28% felt that their choice had been "less clear" and 20% that their voluntariness had been compromised. Previous studies of the acceptability of PITC have used the uptake of testing as an indicator of acceptability. 35, 36 Although they provided evidence of the feasibility of PITC, these studies did not reflect patients' experiences of or views about PITC. Our review of the published literature suggests that PITC is generally acceptable to patients. Studies reported that more than 75% regarded PITC as acceptable, particularly in antenatal clinics. 22 However, findings in pregnant women may not be generalizable to other population groups since these women may be more willing to undergo HIV testing because they believe it will benefit their children. 37 Patients in other clinical settings may find PITC less acceptable, perhaps because of their perceived risk of infection or fear. 37 In our review, evidence from four studies involving small groups of pregnant women indicated that patients were not always aware they had the right to decline HTC in antenatal clinics, perhaps because of the power balance
between patients and health-care providers. 29, 31 However, studies in other regions suggest that women may find the routine offer of HTC acceptable because it "normalizes" the process of HTC.
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Our review has several limitations. It was difficult to retrieve all the documents required to understand national PITC policy fully. Although we contacted WHO country offices, it was not possible to obtain information for some countries and, for others, the date on which policy was adopted was unknown. In addition, the ambiguous language of some documents made it difficult to determine when and in which settings policies were adopted.
Consequently, our data on the years in which PITC policies were adopted may be inaccurate.
We minimized this inaccuracy by asking two reviewers to determine independently the date of policy adoption using the available evidence. Our review of patients' experiences of and views about PITC also has several limitations and the findings must be interpreted with caution. First, our review was subject to a language bias and a publication bias. Second, the majority of studies included took place in antenatal clinics and there may be studies from other clinical settings that we were not able to identify. Some studies that reported on the acceptability of PITC included only small samples of women and did not involve interviews with women who declined an offer of HTC. 28, 31, 32 In addition, the studies included in our review are subject to their own limitations: the majority were nonrandomized studies and the difficulty of reporting and synthesizing evidence from nonrandomized studies is well documented. 39 Moreover, studies were subject to acquiescence bias 40 and, as the questions posed to patients were different in each study, it was difficult to compare their findings.
In general, the evidence suggests that the introduction of PITC in antenatal clinics has been associated with an increase in HIV testing rates. A 2010 WHO report on universal access stated that the testing rate in eastern and southern Africa rose from 48% in 2008 to 50% in 2009. 10 Moreover, with the increased uptake of HTC and the better access to ART that followed from the introduction of PITC, 13 mother-to-child HIV transmission has been virtually eliminated in some countries 13, 24 : in 2009, four of the 25 countries with the highest HIV disease burden achieved the target set by the United Nations General Assembly Special Session on HIV/AIDS of providing at least 80% of HIV-infected pregnant women with ART. 10 In addition, one literature review found that the introduction of PITC in antenatal clinics contributed to the achievement of universal HTC in pregnant women. 41 Moreover, the results of the seven African-based studies included in our review indicate that implementation of PITC led to an increase in the uptake of HTC by pregnant women that ranged from 9.9% 41 the adoption of PITC alone will not achieve universal access to HTC. Other approaches that enable people not attending health-care services to access HIV testing should be developed in parallel to ensure that access to testing is equitable and that individuals with HIV infections are diagnosed before they become symptomatic. In 2011, the HIV Prevention Trials Network study 52 (HPTN052) confirmed that ART was effective for preventing the transmission of HIV in serodiscordant couples. 48 There is a rationale, therefore, for considering and evaluating household or community-based testing in addition to expanding PITC. 49 Data on these alternative approaches would help identify the most effective and appropriate way of implementing HIV testing in specific local contexts, while taking into account the resources available and social constraints. HIV, human immunodeficiency virus; PITC, provider-initiated HIV testing and counselling; PMTCT, prevention of mother-to-child HIV transmission.
a The date the policy was adopted could not be determined for three countries.
b The total exceeds 100% as some countries adopted PITC for more than one target population. experience with or opinion of the health education talk, whereas 9.8% had a "fair," "bad" or "very bad" experience; (ii) 86.3% had a "good" or "very good" experience with or opinion of pretest counselling, whereas 13.7% had a "fair," "bad" or "very bad" experience; (iii) 95.1% had a "good" or "very good" experience with or opinion of post-test counselling, whereas 4.9% had a "fair," "bad" or "very bad" experience Groves, 2010 31 
South Africa
To evaluate women's experiences with HTC 25 Women who had been tested for HIV during their most recent pregnancy (i) 52% believed they had clearly consented to testing and had a positive experience of group and individual education sessions; (ii) 28% said their choice was "less clear" and were less positive about the education sessions; (iii) 20% felt their choice had been compromised (48% of these women expressed the view that they experienced less autonomy in deciding whether to be tested for HIV) Angotti, 2010 28 
Malawi
To determine local perceptions of routine HIV testing and the potential consequences 18 (12 from an ANC attende e sample)
Women that had been offered HTC in an ANC and accepted the offer (i) 22.2% stated that refusing the offer of a test was an option and believed that women could still receive services if they opted out of testing; (ii) the majority who underwent HIV testing stated they were not given the option of refusing in the ANC; (iii) HTC was considered a precondition for receiving care Larsson, 2011 29 
Uganda
To explore women's experiences of, and views on, the opt-out testing policy and 18 Pregnant women attending an ANC (i) Pregnant women recruited from facilities that offered testing on site perceived HIV testing as compulsory, despite pretest group counselling; (ii) generally women thought they could not receive any other ANC service if they declined testing; (iii) women felt obligated to 
